WHO approves first rapid blood test for Ebola

Ebola tests could soon take as little time as 15 minutes.

The World Health Organization has approved the ReEBOV Antigen Rapid Test, created by Corgenix, a U.S. company, searches patients' blood for the Ebola virus. BBC News reports that after trials in West Africa, the test correctly identified 92 percent of people infected by Ebola.

"While less accurate, the antigen test is rapid, easy to perform and does not require electricity," the WHO told BBC News. "It can therefore be used at lower health care facilities or in mobile units for patients in remote settings."

The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE

Sign up for The Week's Free Newsletters

Join more than 350,000 subscribers and keep yourself informed with a selection of The Week’s most interesting, enlightening and entertaining stories - plus daily puzzles.

Join more than 350,000 subscribers and keep yourself informed with a selection of The Week’s most interesting, enlightening and entertaining stories - plus daily puzzles.

Sign up

Conventional Ebola testing requires a laboratory analysis of blood for fragments of the Ebola virus. The WHO recommended that results from the rapid test be confirmed by conventional methods, which are more precise but take between 12 and 24 hours to provide results. Doctors hope the new test will confirm outbreaks in remote areas more efficiently.